Article
Food Science & Technology
Yue-Qin Zeng, Juan-Hua Gu, Liang Chen, Tao-Tao Zhang, Xin-Fu Zhou
Summary: The study showed that chronic administration of gastrodin can decrease aggregation of A beta 42, prevent A beta 42 induced neurotoxicity, reduce levels of A beta plaques and hyperphosphorylated tau, alleviate activation of glial cells and proinflammatory cytokines, and attenuate oxidative stress in the APP/PS1 transgenic mice. The potential mechanisms involve inhibition of A beta enzymes and prevention of GSK3 beta activity. These results suggest that gastrodin may be a potential treatment agent for AD.
JOURNAL OF FUNCTIONAL FOODS
(2021)
Article
Plant Sciences
Caixia Zang, Hui Liu, Junmei Shang, Hanyu Yang, Lu Wang, Chanjuan Sheng, Zihong Zhang, Xiuqi Bao, Yang Yu, Xinsheng Yao, Dan Zhang
Summary: The study demonstrates that GJ-4 improves cognitive deficits in APP/PS1 transgenic mice by reducing A beta levels, inhibiting tau protein phosphorylation, and suppressing neuroinflammatory responses. These findings provide a basis for further development of GJ-4 as a potential treatment for AD.
Article
Geriatrics & Gerontology
Xiao-bo Yang, Heng-bing Zu, Yong-fei Zhao, Kai Yao
Summary: Agomelatine can improve cognitive impairment and ameliorate AD-like pathology in APP/PS1 mice by activating DHCR24 signaling and inhibiting Akt/mTOR and Hes1/Notch1 signaling pathways. It may become a promising drug candidate in the therapy of Alzheimer's disease.
FRONTIERS IN AGING NEUROSCIENCE
(2022)
Article
Nutrition & Dietetics
Anna Mengr, Veronika Strnadova, Stepan Strnad, Vladimir Vrkoslav, Helena Pelantova, Marek Kuzma, Thomas Comptdaer, Blanka Zelezna, Jaroslav Kunes, Marie-Christine Galas, Andrea Pacesova, Lenka Maletinska
Summary: Alzheimer's disease (AD) is characterized by various pathological changes in the brain, including amyloid-beta plaques, neurofibrillary tangles, and neuroinflammation. This study investigated the impact of obesity-induced insulin resistance and inflammation on AD-like pathology in a mouse model. The results showed that a high-fat diet exacerbated AD pathology and inflammation in the brains of the mice, indicating a deleterious effect of obesity-related metabolic abnormalities on the development of AD.
Article
Behavioral Sciences
Xiaoqin Tan, Zhibin Liang, Yingui Li, Yingkun Zhi, Lang Yi, Shasha Bai, Kelly H. Forest, Robert A. Nichols, Yan Dong, Qing X. Li
Summary: Isoorientin, a selective inhibitor of GSK-3 beta, shows therapeutic potential in attenuating AD pathogenic hallmarks and improving cognitive function in transgenic mouse models.
BEHAVIOURAL BRAIN RESEARCH
(2021)
Article
Immunology
Jiawei Zhang, Yaling Zheng, Yao Zhao, Yaxuan Zhang, Yu Liu, Fang Ma, Xiuzhe Wang, Jianliang Fu
Summary: Andrographolide can significantly alleviate cognitive impairments, reduce amyloid-β deposition, inhibit microglial activation, and decrease the secretion of proinflammatory factors in APP/PS1 mice. Furthermore, transcriptome sequencing analysis revealed that Andro could significantly decrease the expression of various genes associated with inflammation in APP/PS1 mice, which was further validated by qRT-PCR. Our results suggest that Andro might be a potential therapeutic drug for AD by regulating neuroinflammation.
INTERNATIONAL IMMUNOPHARMACOLOGY
(2021)
Article
Cell Biology
Ning Bai, Na Li, Rong Cheng, Yi Guan, Xiong Zhao, Zhijie Song, Hongde Xu, Fei Yi, Bo Jiang, Xiaoman Li, Xuan Wu, Cui Jiang, Tingting Zhou, Qiqiang Guo, Wendong Guo, Yanling Feng, Zhuo Wang, Mengtao Ma, Yang Yu, Zhanyou Wang, Shengping Zhang, Chuangui Wang, Weidong Zhao, Shihui Liu, Xiaoyu Song, Hua Liu, Liu Cao
Summary: Aging is a primary risk factor for neurodegenerative diseases, and inhibiting SIRT2 has been found to improve cognitive impairment in an Alzheimer's disease model. This improvement is attributed to the enhanced acetylation of APP, leading to non-amyloidogenic processing and increased soluble APP-alpha.
Article
Biochemistry & Molecular Biology
Oksana Fihurka, Yuzhu Hong, Jiyu Yan, Breanna Brown, Xiaoyang Lin, Ning Shen, Yanhong Wang, Haohan Zhao, Marcia N. Gordon, David Morgan, Qingyu Zhou, Ping Chang, Chuanhai Cao
Summary: The research found that low-dose THC treatment through intranasal delivery significantly slows memory decline, decreases the levels of Alzheimer's disease-related peptides, and promotes reductions in tau protein levels and changes in mitochondrial function markers. Blood biochemical parameters showed insignificant changes during treatment. Intranasal delivery is a non-invasive and convenient method that targets therapeutics to the brain, minimizing systemic exposure to avoid adverse effects.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Neurosciences
Qiwei Zhang, Wei Zhao, Yue Hou, Xinxin Song, Haiyang Yu, Jinghe Tan, Yanmeng Zhou, Han-Ting Zhang
Summary: This study found that appropriate supplementation of beta-glucan during the progression of AD can improve cognitive impairment and reduce A beta plaque deposition. Supplementation of beta-glucan can also promote changes in the composition of the intestinal flora, thereby changing the flora metabolites in the intestinal content and reduce the activation of inflammatory factors and microglia in the cerebral cortex and hippocampus through the brain-gut axis. While reducing the expression of inflammatory factors in the hippocampus and cerebral cortex, thereby controlling neuroinflammation.
CNS NEUROSCIENCE & THERAPEUTICS
(2023)
Article
Neurosciences
Bijayani Sahu, Amy R. Mackos, Angela M. Floden, Loren E. Wold, Colin K. Combs
Summary: This study investigated the effects of particulate matter exposure on AD-related brain changes using a transgenic disease model. The results showed that chronic particulate matter exposure exacerbates AD by increasing A beta plaque load, gliosis, and the brain inflammatory status.
JOURNAL OF ALZHEIMERS DISEASE
(2021)
Article
Neurosciences
Sally Kelliny, Liying Lin, Isaac Deng, Jing Xiong, Fiona Zhou, Mohammed Al-Hawwas, Larisa Bobrovskaya, Xin-Fu Zhou
Summary: The study aimed to develop an AD animal model combining neuropathological features of sporadic AD in humans with amyloid plaques seen in transgenic mice. STZ treatment caused disturbance in multiple metabolic and cell signaling pathways in the brain, leading to amyloid plaque accumulation and tau phosphorylation.
MOLECULAR NEUROBIOLOGY
(2021)
Article
Multidisciplinary Sciences
Maria Clara Selles, Juliana T. S. Fortuna, Yasmin P. R. de Faria, Luciana Domett Siqueira, Ricardo Lima-Filho, Beatriz M. Longo, Robert C. Froemke, Moses V. Chao, Sergio T. Ferreira
Summary: Alzheimer's disease (AD) is characterized by neurodegeneration, memory loss, and social withdrawal. Brain inflammation has been identified as a key mechanism in AD, and oxytocin, a pro-social neuropeptide, has shown potential therapeutic effects. In experiments, amyloid-B peptide oligomers (ABOs) reduced oxytocin expression, but treatment with oxytocin prevented microglial activation. In a mouse model of AD, intranasal oxytocin attenuated microglial activation, promoted deposition of AB in neuroprotective plaques, and improved social and non-social memory deficits.
Article
Integrative & Complementary Medicine
Qing-Hua Long, Yong-Gui Wu, Li-Ling He, Li Ding, Ai-Hua Tan, He-Yuan Shi, Ping Wang
Summary: Suan-Zao-Ren Decoction (SZRD) can improve cognitive function and alleviate neural degeneration in APP/PS1 transgenic mice by reducing A accumulation and neuroinflammation through the JAK2/STAT3 pathway.
Article
Biochemistry & Molecular Biology
Tiantian Zhang, Shuangxi Zhang, Yunhua Peng, Yongyao Wang, Peipei Gao, Yachong Hu, Zhen Wang, Mami Noda, Midori Hiramatsu, Jiankang Liu, Jiangang Long
Summary: Oral administration of safflower leaf powder significantly improved cognitive impairment in APP/PS1 mice, with neuroprotective effects that reduce inflammation, oxidative stress, and excessive astrocyte activation. Safflower leaf may be a promising food for preventing and alleviating AD-related dementia.
Article
Neurosciences
Zongyang Li, Yuan Zhang, Yueyang Zheng, Wenlan Liu, Xiejun Zhang, Weiping Li, Di Zhang, Qian Cai, Sicen Wang, Xiangbao Meng, Guodong Huang
Summary: The PPAR gamma agonist 15d-PGJ2 shows promising effects against Alzheimer's disease by inhibiting A beta plaques, neuroinflammation, and increasing brain glucose uptake. This therapeutic approach may work by activating PPAR gamma-dependent signaling pathways.
Article
Behavioral Sciences
Liying Lin, Xin-Fu Zhou, Larisa Bobrovskaya
Summary: This study demonstrates that blocking p75(NTR) signaling can alleviate depressive and anxiety-like behaviors in chronically stressed mice and improve dendritic spinogenesis of neurons under stress.
BEHAVIOURAL BRAIN RESEARCH
(2021)
Article
Medicine, Research & Experimental
Wei Ma, Jin-Wei Yang, Xian-Bin Wang, Tao Luo, Lei Zhou, Alfonso Lagares, Hongyun Li, Zhang Liang, Kuang-Pin Liu, Cheng-Hao Zang, Chun-Yan Li, Zhen Wu, Jian-Hui Guo, Xin-Fu Zhou, Li-Yan Li
Summary: Neurogenesis has been observed in the adult peripheral nervous system, with satellite glial cells (SGCs) identified as potential neuronal precursors that are regulated by proBDNF. This process differs from neurogenesis in the central nervous system and is negatively regulated by proBDNF.
BIOMEDICINE & PHARMACOTHERAPY
(2021)
Article
Biochemistry & Molecular Biology
Chun-Rui Yang, Hong-Jun Ding, Miao Yu, Fiona-H Zhou, Chen-Yang Han, Rui Liang, Xiao-Yang Zhang, Xiang-Lian Zhang, Fan-Jie Meng, Shuo Wang, De-Dong Li, Wei-Zong Sun, Bin Meng, Xin-Fu Zhou
Summary: The proBDNF/p75NTR signaling pathway plays an important role in inflammatory arthritis pain and rheumatoid arthritis (RA). The expression levels of p75NTR and proBDNF are significantly increased in RA patients compared to healthy donors, and they are positively correlated with Disease Activity Score. In a mouse model, blocking the pathway with p75ECD-Fc effectively blocks inflammatory responses and relieves pain.
Article
Biochemistry & Molecular Biology
Donghui Liu, Grigori Rychkov, Plinio Hurtado, Hai-Yun Luo, Tao Zhang, Larisa Bobrovskaya, Xin-Fu Zhou
Summary: This study demonstrates the successful conversion of human fibroblasts into induced neural stem cells (iNSCs) using small molecules. The iNSCs derived from fibroblasts have similar gene expression profiles to genuine NSCs, and have the ability to proliferate and differentiate into glial cells and functional neurons.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Neurosciences
Sally Kelliny, Jing Xiong, Larisa Bobrovskaya, Xin-Fu Zhou
Summary: The study found that Edaravone (EDR) can improve memory and cognitive impairment, alleviate motor deficits, and reduce Tau pathology levels in an animal model of frontotemporal dementia (FTD).
NEUROTOXICITY RESEARCH
(2021)
Article
Neurosciences
Shaun Cade, Xin-Fu Zhou, Larisa Bobrovskaya
Summary: Alzheimer's disease is a neurodegenerative condition that predominantly affects elderly individuals. There is currently no definitive treatment to halt its progression. One therapeutic strategy involves targeting synaptic plasticity mechanisms to regenerate lost synapses. However, the molecular mechanisms that render the aging brain susceptible to synaptic dysfunction in Alzheimer's disease remain unresolved.
REVIEWS IN THE NEUROSCIENCES
(2022)
Article
Multidisciplinary Sciences
Wei-Yun Shen, Cong Luo, Plinio Reinaldo Hurtado, Xiao-Jing Liu, Ru-Yi Luo, Hui Li, Zhao-Lan Hu, Jun-Mei Xu, Elizabeth J. Coulson, Ming Zhao, Xin-Fu Zhou, Ru-Ping Dai
Summary: This study found that the inappropriate expansion of antibody-secreting cells (ASCs) in systemic lupus erythematosus (SLE) is associated with the signaling of brain-derived neurotrophic factor precursor (proBDNF) and its receptor p75(NTR). By inhibiting proBDNF, p75(NTR), or specifically knocking out p75(NTR) in CD19(+) B cells, lupus mice can be treated, reducing the production of autoantibodies and kidney injury.
Article
Pharmacology & Pharmacy
Ling Wang, Yue-Qin Zeng, Juan-Hua Gu, Rui Song, Peng-Hui Cang, Yong-Xuan Xu, Xiao-xia Shao, Li-Jin Pu, Hai-Yun Luo, Xin-Fu Zhou
Summary: Oxidative stress plays a crucial role in diabetic cardiomyopathy, and the novel oral edaravone (OED) has shown potential in alleviating oxidative stress and improving diastolic dysfunction. OED reduced oxidative stress and improved cardiac parameters in type 2 diabetic rats, as well as reduced reactive oxygen species and cell damage in H9c2 cells. These effects were mediated by the activation of the Nrf2 signaling pathway.
EUROPEAN JOURNAL OF PHARMACOLOGY
(2022)
Article
Neurosciences
Li-Qin Zhao, Ankit Parikh, Yun-Xia Xiong, Qing-Yan Ye, Ying-Guo, Xin-Fu Zhou, Hai-Yun Luo
Summary: This study assessed the effect and mechanisms of oral edaravone on a rat model of middle cerebral artery occlusion. The results showed that oral edaravone improved sensorimotor functions, reduced cerebral infarction area, and provided neuroprotection by minimizing oxidative stress and alleviating synaptic damage.
NEUROTOXICITY RESEARCH
(2022)
Article
Psychology, Biological
Liying Lin, Mauritz Frederick Herselman, Xin-Fu Zhou, Larisa Bobrovskaya
Summary: Corticosterone can induce depressive-like and anxiety-like behaviors in mice, as well as differential changes in proBDNF and mBDNF in various brain regions and peripheral tissues. ProBDNF may participate in the development of depressive behaviors in corticosterone-treated animals.
PHYSIOLOGY & BEHAVIOR
(2022)
Article
Endocrinology & Metabolism
Jing Xiong, Isaac Deng, Sally Kelliny, Liying Lin, Larisa Bobrovskaya, Xin-Fu Zhou
Summary: This study investigates the effects of high fat diet-induced obesity on tau phosphorylation and its relationship with Alzheimer's disease and type 2 diabetes. The results suggest that diet-induced obesity exacerbates tau pathology and induces T2DM in transgenic mice expressing the P301L mutant human tau, providing a useful model for investigating the underlying biochemical changes and mechanisms associated with metabolic disorders and AD tauopathy.
METABOLIC BRAIN DISEASE
(2022)
Review
Neurosciences
Liu-Lin Xiong, Li Chen, Isaac Bul Deng, Xin-Fu Zhou, Ting-Hua Wang
Summary: This review summarizes the current research progress on the p75NTR signaling in neurological deficits and introduces the therapeutic approaches targeting p75NTR to attenuate pathological changes. The role of p75NTR in regulating neurodegenerative diseases has been discussed, as well as its potential as a biomarker for disease severity evaluation and a druggable target for drug development. The introduction of small molecule compounds targeting p75NTR provides a new approach for attenuating neurodegeneration and cell death.
EUROPEAN JOURNAL OF NEUROSCIENCE
(2022)
Article
Nutrition & Dietetics
Mauritz F. Herselman, Sheree Bailey, Permal Deo, Xin-Fu Zhou, Kate M. Gunn, Larisa Bobrovskaya
Summary: Academic stress negatively impacts mental health in undergraduate students, but walnut consumption may have a protective effect against some of these negative impacts. However, further research is needed to understand the sex-dependent mechanisms involved.
Article
Medicine, Research & Experimental
Zhao-Lan Hu, Cong Luo, Plinio Reinaldo Hurtado, Hui Li, Shuang Wang, Bo Hu, Jun-Mei Xu, Yang Liu, Shi-Qing Feng, Ernesto Hurtado-Perez, Kang Chen, Xin-Fu Zhou, Chang-Qi Li, Ru-Ping Dai
Summary: The study found that proBDNF from immune cells promotes the immunopathogenesis of multiple sclerosis (MS). Monoclonal Ab-proB may be a promising therapeutic agent for treating MS.
Article
Biochemistry & Molecular Biology
Hui-Ting Huang, Shun-Fen Tzeng
Summary: Our study demonstrates the role of interleukin-33 (IL-33) in a demyelinating mouse model induced by cuprizone (CPZ), showing that IL-33 can alleviate the reduction of APC+ OLs and the decline of IL-33 levels in the corpus callosum, and promote the expression of myelin basic protein (MBP).
NEUROCHEMISTRY INTERNATIONAL
(2024)